Dreem, the US-based developer of an electronic sleep aid, has raised $35m in a funding round co-led by Johnson & Johnson Innovation – JJDC, the corporate venturing division of pharmaceutical firm Johnson & Johnson.
French state-owned investment bank Bpifrance co-led the round with Johnson & Johnson.
Founded in 2014 as Rythm, Dreem is the creator of a headband (pictured) that monitors the wearer’s brain activity at night using EEG electrodes, utilising precisely timed auditory stimulation to help the user fall…
